Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146432
Status:
COMPLETED
Last Update Posted:
2009-08-25
First Post:
2005-09-06
Brief Title:
Immunoadsorption of LPS C5a and IL-6 in Severe Sepsis and Septic Shock ISASS-1
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Prospective Controlled Pilot Trial Treatment of Patients in Severe Sepsis and Septic Shock With Immunoadsorption of LPS IL-6 C5a
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether immunoadsorption of LPS Il-6 and C5a reduces systemic hyperinflammation improves immune function and improves organ function in patients with severe sepsis and septic shock
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None